Benitec Biopharma Ltd ADR Cash Flow Reinvestment Rate

Latest as of September 2018: 0.00x

Benitec Biopharma Ltd ADR cash flow reinvestment rate. Benitec Biopharma Ltd ADR (BNTC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2018, reinvesting $26.00K (capex $26.00K ) from operating cash flow of $5.87 Million. See BNTC financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$26.00K
Capex + Investments

Operating Cash Flow

$5.87 Million
USD

Capital Expenditures

$26.00K
USD

Cash Flow Reinvestment Rate of Benitec Biopharma Ltd ADR (2019–2019)

Cash flow reinvestment rate of Benitec Biopharma Ltd ADR from 2019 to 2019. Historical reinvestment intensity for Benitec Biopharma Ltd ADR across 1 annual periods. Explore cash flow to debt ratio of Benitec Biopharma Ltd ADR to assess how comfortably operating cash covers total debt obligations.

Benitec Biopharma Ltd ADR Cash Flow Reinvestment Rate by Year (2019–2019)

Benitec Biopharma Ltd ADR cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Benitec Biopharma Ltd ADR. For the full cash flow conversion analysis, see Benitec Biopharma Ltd ADR (BNTC) cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.20x $973.40K $4.79 Million $403.40K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow